Arbutus Biopharma Corp. (ABUS)

5.19 -0.01 (-0.19%) USD  |  NASDAQ  |  Aug 26, 16:00
5.19 0.00 (0.00%) After-Hours: 16:05
More

Arbutus Biopharma EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
March 04, 2026 --
November 14, 2025 --
September 10, 2025 --
August 11, 2025 --
August 06, 2025 --
June 25, 2025 --
May 21, 2025 --
May 15, 2025 --
May 14, 2025 --
March 31, 2025 --
March 28, 2025 --
March 27, 2025 --
February 26, 2025 --
Date Value
November 20, 2024 --
November 06, 2024 --
September 05, 2024 --
August 02, 2024 --
August 01, 2024 --
June 07, 2024 --
June 06, 2024 --
June 05, 2024 --
May 03, 2024 --
March 01, 2024 --
February 29, 2024 --
January 11, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Moderna, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Legend Biotech Corp. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade